Schedule 13G ownership disclosure

SILEXION THERAPEUTICS CORP

Ordinary shares, par value $0.0135 per share · CUSIP: G1281K122

Event date: 2025-09-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Lind Global Fund III LP

    Shares: 224,050 · Class: 9.9%

  • Lind Global Partners III LLC

    Shares: 224,050 · Class: 9.9%

  • EASTON JEFF

    Shares: 224,050 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-003514
Form type
SCHEDULE 13G
Filer
Lind Global Fund III LP
CIK
CIK 2071860
Filed
Sep 18, 2025
Reporting period
Sep 12, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub